位置:成果数据库 > 期刊 > 期刊详情页
依那西普对类风湿关节炎患者骨代谢生化指标、骨密度的影响
  • ISSN号:1001-5213
  • 期刊名称:中国医院药学杂志
  • 时间:2012.8.15
  • 页码:1206-1208
  • 分类:R969[医药卫生—药理学;医药卫生—药学]
  • 作者机构:[1]桂林医学院附属医院风湿免疫科,广西桂林541001, [2]桂林医学院附属医院临床药理研究室,广西桂林541001
  • 相关基金:[基金项目]国家自然科学基金项目(编号:81160376)
  • 相关项目:青蒿琥酯干预下TRAF6、Foxp3在大鼠佐剂性关节炎滑膜细胞中表达的影响
中文摘要:

目的:研究类风湿关节炎患者接受依那西普(etanercept,ETN)治疗52周后血清骨代谢生化指标、骨密度改变。方法:39例患者分为对照组(MTX7.5 mg/周逐渐加量至15 mg/周,3例患者于第8周时最大剂量为20 mg/周);治疗组17例(MTX用法同前,其中2例患者于第8周时最大剂量为20 mg/周,ETN:25 mg,每周2次,皮下注射)。于治疗前、12周、26周、52周分别检测骨保护素(OPG)、血清骨钙素(OC)、降钙素(CT)、甲状腺旁素(iPTH)。并行腰椎及股骨不同部位骨密度(BMD)测定。结果:2组在治疗前血清OPG水平即有显著降低,对照组随着治疗时间的持续而进一步降低。治疗组在治疗26周后出现升高,2组比较有统计学差异(P〈0.01);而血清iPTH在治疗前2组均有显著升高,对照组随着治疗时间的持续而进一步升高。治疗组在治疗12周后出现升高,2组比较有统计学差异(P〈0.01);2组患者腰椎、股骨颈、股骨沃德三角BMD比较有统计学意义(P〈0.01)。结论:应用依那西普治疗类风湿关节炎能减少骨丢失、有效改善患者骨质疏松。

英文摘要:

OBJECTIVE To investigate the changes of serum bone metabolis indicators and bone mineral density in the patients of rheumatism arthritis after the treatment of etanercept(ETN) and methotrexate plus etanercept(MTX+ETN).METHODS 39 cases of patients were divided into two groups,which were nominated as MTX group and MTX+ETN group.MTX group contained 22 cases,taking MTX only.And the others went to ENT+MTX group taking ENT and MTX treatment.The MTX dose started at 7.5 mg per week.But some patients in two groups could add their dose of MTX to 20 mg per week before week 8.Petients took ENT 25 mg twice a week by subcutaneous injected.At week 0(before thetreatment),12,26,52 weeks some items were tested respectively.The levels of osteoprotegerin(OPG)were tested by enzyme-linked immuno sorbent assaythe.The serum osteocalcin(OC)were tested by Ria method and calcitonin(CT).The thyroid side element(iPTH)were tested by chemiluminescence method.All patients had bone mineral density(BMD) examined.The numerical values above were analysed statistically.RESULTS The levels of OPG in two groups reduced in patients before treatment,and further reduced in MTX group but went up in the patients of MTX+ETN group at week 26.The differences were obviously significant(P〈0.01).The iPTH levels rose in two groups and increased more in MTX group.the MTX+ENT group showed OPG rising only at week 12.Also the diversity were significantly marked(P〈0.01).The levels of serum calciumphosphorus CT and alkaline phosphatase didn’t showed different in statistics.The lumbar vertebra’neck of femur and femoral ward triangle BMD were checked differently in statistics.CONCLUSION ENT could decrease bone resorption and improve osteoporosis.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国医院药学杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中国药学会
  • 主编:陈华庭
  • 地址:武汉市汉口胜利街155号
  • 邮编:430014
  • 邮箱:pharmacy@vip.163.com
  • 电话:027-82836596
  • 国际标准刊号:ISSN:1001-5213
  • 国内统一刊号:ISSN:42-1204/R
  • 邮发代号:38-50
  • 获奖情况:
  • 曾获中国药学会优秀期刊二等奖,中国科协优秀期刊三等奖,湖北省优秀期刊奖
  • 国内外数据库收录:
  • 美国国际药学文摘,美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:53772